Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Feb 15;266(1):251–259. doi: 10.1042/bj2660251

Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases.

M J King 1, G J Sale 1
PMCID: PMC1131122  PMID: 1689998

Abstract

Insulin stimulates autophosphorylation of the insulin receptor on multiple tyrosines in three domains: tyrosines 1316 and 1322 in the C-terminal tail, 1146, 1150 and 1151 in the tyrosine-1150 domain, and possibly 953, 960 or 972 in the juxtamembrane domain. In the present work the sequence of dephosphorylation of the various autophosphorylation sites by particulate and cytosolic preparations of phosphotyrosyl-protein phosphatase from rat liver was studied with autophosphorylated human placental insulin receptor as substrate. Both phosphatase preparations elicited a broadly similar pattern of dephosphorylation. The tyrosine-1150 domain in triphosphorylated form was found to be exquisitely sensitive to dephosphorylation, and was dephosphorylated 3-10-fold faster than the di- and monophosphorylated forms of the tyrosine-1150 domain or phosphorylation sites in other domains. The major route for dephosphorylation of the triphosphorylated tyrosine-1150 domain involved dephosphorylation of one of the phosphotyrosyl pair, 1150/1151, followed by phosphotyrosyl 1146 to generate a species monophosphorylated mainly (greater than 80%) at tyrosine 1150 or 1151. Insulin receptors monophosphorylated in the tyrosine-1150 domain disappeared slowly, and overall the other domains were completely dephosphorylated faster than the tyrosine-1150 domain. Dephosphorylation of the diphosphorylated C-terminal domain yielded insulin receptor in which the domain was singly phosphorylated at tyrosine 1322. Triphosphorylation of the insulin receptor in the tyrosine-1150 domain appears important in activating the receptor tyrosine kinase to phosphorylate other proteins. The extreme sensitivity of the triphosphorylated form of the tyrosine-1150 domain to dephosphorylation may thus be important in terminating or regulating insulin-receptor tyrosine kinase action and insulin signalling.

Full text

PDF
251

Images in this article

254Fig. 1.
on p.254
256Fig. 2.
on p.256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chou C. K., Dull T. J., Russell D. S., Gherzi R., Lebwohl D., Ullrich A., Rosen O. M. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem. 1987 Feb 5;262(4):1842–1847. [PubMed] [Google Scholar]
  2. Ebina Y., Araki E., Taira M., Shimada F., Mori M., Craik C. S., Siddle K., Pierce S. B., Roth R. A., Rutter W. J. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A. 1987 Feb;84(3):704–708. doi: 10.1073/pnas.84.3.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kasuga M., Zick Y., Blithe D. L., Crettaz M., Kahn C. R. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature. 1982 Aug 12;298(5875):667–669. doi: 10.1038/298667a0. [DOI] [PubMed] [Google Scholar]
  4. King M. J., Sale G. J. Assay of phosphotyrosyl protein phosphatase using synthetic peptide 1142-1153 of the insulin receptor. FEBS Lett. 1988 Sep 12;237(1-2):137–140. doi: 10.1016/0014-5793(88)80187-x. [DOI] [PubMed] [Google Scholar]
  5. King M. J., Sale G. J. Insulin-receptor phosphotyrosyl-protein phosphatases. Biochem J. 1988 Dec 15;256(3):893–902. doi: 10.1042/bj2560893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  7. Maegawa H., McClain D. A., Freidenberg G., Olefsky J. M., Napier M., Lipari T., Dull T. J., Lee J., Ullrich A. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. J Biol Chem. 1988 Jun 25;263(18):8912–8917. [PubMed] [Google Scholar]
  8. McClain D. A., Maegawa H., Levy J., Huecksteadt T., Dull T. J., Lee J., Ullrich A., Olefsky J. M. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis. J Biol Chem. 1988 Jun 25;263(18):8904–8911. [PubMed] [Google Scholar]
  9. Morgan D. O., Roth R. A. Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin. Proc Natl Acad Sci U S A. 1987 Jan;84(1):41–45. doi: 10.1073/pnas.84.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rosen O. M., Herrera R., Olowe Y., Petruzzelli L. M., Cobb M. H. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3237–3240. doi: 10.1073/pnas.80.11.3237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sale G. J., Fujita-Yamaguchi Y., Kahn C. R. Characterization of phosphatidylinositol kinase activity associated with the insulin receptor. Eur J Biochem. 1986 Mar 3;155(2):345–351. doi: 10.1111/j.1432-1033.1986.tb09497.x. [DOI] [PubMed] [Google Scholar]
  12. Sale G. J. Recent progress in our understanding of the mechanism of action of insulin. Int J Biochem. 1988;20(9):897–908. doi: 10.1016/0020-711x(88)90173-5. [DOI] [PubMed] [Google Scholar]
  13. Sale G. J., Smith D. M. Serine phosphorylations triggered by the insulin receptor. Cell Signal. 1989;1(3):205–218. doi: 10.1016/0898-6568(89)90038-7. [DOI] [PubMed] [Google Scholar]
  14. Smith D. M., King M. J., Sale G. J. Two systems in vitro that show insulin-stimulated serine kinase activity towards the insulin receptor. Biochem J. 1988 Mar 1;250(2):509–519. doi: 10.1042/bj2500509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Smith D. M., Sale G. J. Characterization of sites of serine phosphorylation in human placental insulin receptor copurified with insulin-stimulated serine kinase activity by two-dimensional thin-layer peptide mapping. FEBS Lett. 1989 Jan 2;242(2):301–304. doi: 10.1016/0014-5793(89)80489-2. [DOI] [PubMed] [Google Scholar]
  16. Smith D. M., Sale G. J. Evidence that a novel serine kinase catalyses phosphorylation of the insulin receptor in an insulin-dependent and tyrosine kinase-dependent manner. Biochem J. 1988 Dec 15;256(3):903–909. doi: 10.1042/bj2560903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tavaré J. M., Denton R. M. Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping. Biochem J. 1988 Jun 1;252(2):607–615. doi: 10.1042/bj2520607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tavaré J. M., O'Brien R. M., Siddle K., Denton R. M. Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. Biochem J. 1988 Aug 1;253(3):783–788. doi: 10.1042/bj2530783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tonks N. K., Diltz C. D., Fischer E. H. Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 1988 May 15;263(14):6731–6737. [PubMed] [Google Scholar]
  20. Tonks N. K., Diltz C. D., Fischer E. H. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 1988 May 15;263(14):6722–6730. [PubMed] [Google Scholar]
  21. Tornqvist H. E., Avruch J. Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity. J Biol Chem. 1988 Apr 5;263(10):4593–4601. [PubMed] [Google Scholar]
  22. Tornqvist H. E., Gunsalus J. R., Nemenoff R. A., Frackelton A. R., Pierce M. W., Avruch J. Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells. J Biol Chem. 1988 Jan 5;263(1):350–359. [PubMed] [Google Scholar]
  23. Tornqvist H. E., Pierce M. W., Frackelton A. R., Nemenoff R. A., Avruch J. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem. 1987 Jul 25;262(21):10212–10219. [PubMed] [Google Scholar]
  24. Ullrich A., Bell J. R., Chen E. Y., Herrera R., Petruzzelli L. M., Dull T. J., Gray A., Coussens L., Liao Y. C., Tsubokawa M. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. 1985 Feb 28-Mar 6Nature. 313(6005):756–761. doi: 10.1038/313756a0. [DOI] [PubMed] [Google Scholar]
  25. White M. F., Shoelson S. E., Keutmann H., Kahn C. R. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem. 1988 Feb 25;263(6):2969–2980. [PubMed] [Google Scholar]
  26. Yu K. T., Czech M. P. Tyrosine phosphorylation of the insulin receptor beta subunit activates the receptor-associated tyrosine kinase activity. J Biol Chem. 1984 Apr 25;259(8):5277–5286. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES